Table 1.
Signalment, and main clinical and pathological findings in seven cats with pericardial lymphoma
| Cat | Signalment | Age (y) | FeLV status | Thoracic US | Cytology | Histology | Immunophenotype | Treatment | Follow-up* |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DSH Mn | 7 | Negative | Yes | Yes (pericardium) Large-cell lymphoma | Yes Large-cell lymphoma | IHC and ICC | None | Died 7 days |
| CD3+ | |||||||||
| CD8+ | |||||||||
| CD79a- | |||||||||
| T-cell | |||||||||
| 2 | DSH Fs | 3 | Positive | Yes | NP | Yes Intermediate-cell lymphoma | IHC | None | Died 10 days |
| CD79a+ | |||||||||
| CD3- | |||||||||
| B-cell | |||||||||
| FeLV p27+ | |||||||||
| FeLVgp70+ | |||||||||
| 3 | DSH Fs | 4 | Positive | Yes | Yes (pleural effusion and pericardic effusion and pericardium) Medium-size cell lymphoma | NP | NP | Modified UWM | Alive (750 days on complete remission) |
| 4 | DSH Fs | 5 | Positive | Yes | Yes (pleural effusion) Large-cell lymphoma | NP | ICC | Doxorubicin | Died 10 days |
| CD3+ | |||||||||
| CD79a- | |||||||||
| CD20- | |||||||||
| T-cell | |||||||||
| 5 | DSH Mn | 2 | Positive | Yes | Yes (pleural effusion and pericardium) Large-cell lymphoma | NP | ICC | Prednisone | Died 11 days |
| CD3+ | |||||||||
| CD79a- | |||||||||
| CD20- | |||||||||
| T-cell | |||||||||
| 6 | DSH Fs | 5 | Positive | Yes | Yes (pleural and pericardial effusion) Small-cell lymphoma | Yes Small-cell lymphocytic lymphoma | IHC | None | Died 9 days |
| CD79a+ | |||||||||
| CD3- | |||||||||
| B-cell | |||||||||
| FeLV p27+ | |||||||||
| FeLV gp70- | |||||||||
| 7 | DSH Fs | 10 | Positive (performed only on IHC) | No | Yes (pleural effusion) Intermediate-cell lymphoma | Yes Lymphoblastic intermediate-cell lymphoma | IHC | None | Unknown |
| CD79a+ | |||||||||
| CD3- | |||||||||
| B-cell | |||||||||
| FeLV p27+ | |||||||||
| FeLV gp70+ |
FeLV = feline leukaemia virus; US = ultrasonography; DSH = domestic shorthair; Mn = male neutered; Fs = female spayed; IHC = immunohistochemistry; NP = not performed; ICC = immunocytochemistry; UWM = University of Wisconsin–Madison chemotherapy protocol
*
The survival time is defined as the time from diagnosis to death